Premium
Pneumatosis intestinalis in an infant undergoing bone marrow transplantation for Wiskott–Aldrich syndrome
Author(s) -
Uçkan Duygu,
Çetin Mualla,
Haliloðlu Mithat,
Çiftçi Arbay O.,
Tuncer Murat A.,
Tezcan Ýlhan
Publication year - 2001
Publication title -
pediatric transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.457
H-Index - 69
eISSN - 1399-3046
pISSN - 1397-3142
DOI - 10.1034/j.1399-3046.2001.00001.x
Subject(s) - medicine , immunosuppression , neutropenia , pneumatosis intestinalis , wiskott–aldrich syndrome , sepsis , bone marrow , transplantation , surgery , gastroenterology , immunology , chemotherapy , biochemistry , chemistry , gene
A 7‐month‐old patient with Wiskott–Aldrich syndrome (WAS) developed pneumatosis intestinalis (PI) in the immediate post‐transplant period after receiving paternal human leucocyte antigen (HLA) phenotypically matched bone marrow (BM). PI has been described in patients with congenital or acquired immunodeficiency states and after bone marrow transplantation (BMT). To our knowledge, the condition has not been described in WAS. The underlying bowel mucosa damage as a result of the history of massive rectal bleeding, the effects of the conditioning regimen, immunosuppression, neutropenia, and infection, may all have contributed to the development of PI. Although the condition resolved by conservative management alone, the patient developed Klebsiella pneumonia sepsis, interstitial pneumonitis, failed to engraft, and died on day +66 following a second infusion of stem cells mobilized from his father's peripheral blood.